Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
23.02
+0.14 (0.59%)
Jul 9, 2025, 2:51 PM - Market open
THNR Holdings Information
THNR is an equity ETF with a total of 22 individual holdings. The top holdings are Eli Lilly and Company stock at 12.41%, Novo Nordisk at 11.01%, Regeneron Pharmaceuticals at 7.21%, Amgen at 6.90%, and Chugai Pharmaceutical at 6.34%.
Total Holdings
22
Top 10 Percentage
69.47%
Asset Class
Equity
ETF Category
Health
Assets
2.98M
PE Ratio
19.28
Sector Allocation
Top 25 Holdings
As of Jul 3, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.41% |
| 2 | NVO | Novo Nordisk A/S | 11.01% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.21% |
| 4 | AMGN | Amgen Inc. | 6.90% |
| 5 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 6.34% |
| 6 | PFE | Pfizer Inc. | 5.27% |
| 7 | GILD | Gilead Sciences, Inc. | 5.15% |
| 8 | MRK | Merck & Co., Inc. | 5.10% |
| 9 | ABBV | AbbVie Inc. | 5.08% |
| 10 | SWX: ROG | Roche Holding AG | 4.98% |
| 11 | AZN | AstraZeneca PLC | 4.78% |
| 12 | HKG: 1801 | Innovent Biologics, Inc. | 4.34% |
| 13 | TYO: 4507 | Shionogi & Co., Ltd. | 4.22% |
| 14 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 3.80% |
| 15 | HIMS | Hims & Hers Health, Inc. | 3.50% |
| 16 | CPH: ZEAL | Zealand Pharma A/S | 2.35% |
| 17 | VKTX | Viking Therapeutics, Inc. | 1.99% |
| 18 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.67% |
| 19 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 1.63% |
| 20 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.19% |
| 21 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 0.87% |
| 22 | n/a | DEPOSITS WITH BROKER FOR SHORT POSITIONS | 0.19% |
As of Jul 3, 2025